Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel O Persky
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
190 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Hospital
Mobile, Alabama, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- Nea Baptist Memorial Hospital
Jonesboro, Arkansas, United States
- Nea Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Kaiser Permanente-Fresno
Fresno, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Kaiser Permanente-Redwood City
Redwood City, California, United States
- Kaiser Permanente-Richmond
Richmond, California, United States
- Kaiser Permanente-Roseville
Roseville, California, United States
- Kaiser Permanente Sacramento Medical Center
Sacramento, California, United States
- Kaiser Permanente-South Sacramento
Sacramento, California, United States
- Kaiser Permanente-San Francisco
San Francisco, California, United States
- Kaiser Permanente-Santa Teresa-San Jose
San Jose, California, United States
- Kaiser Permanente San Leandro
San Leandro, California, United States
- Kaiser Permanente-San Rafael
San Rafael, California, United States
- Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, United States
- Kaiser Permanente-Santa Rosa
Santa Rosa, California, United States
- Kaiser Permanente-South San Francisco
South San Francisco, California, United States
- Kaiser Permanente-Stockton
Stockton, California, United States
- Kaiser Permanente Medical Center-Vacaville
Vacaville, California, United States
- Kaiser Permanente-Vallejo
Vallejo, California, United States
- Kaiser Permanente-Walnut Creek
Walnut Creek, California, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Hawaii Cancer Care Inc - Waterfront Plaza
Honolulu, Hawaii, United States
- Hawaii Cancer Care Inc-Liliha
Honolulu, Hawaii, United States
- Kaiser Permanente Moanalua Medical Center
Honolulu, Hawaii, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Kuakini Medical Center
Honolulu, Hawaii, United States
- Queen'S Cancer Center - Kuakini
Honolulu, Hawaii, United States
- Queen'S Medical Center
Honolulu, Hawaii, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Nov 2010
- Primary completion
- 30 Dec 2015
- Completion
- 6 Mar 2027
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 83
- Registry id
- NCT00972478
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.